• Featured - New theory of why midcontinent faults produce earthquakes
• Featured - One more step on the path to quantum computers
• Salmonella Outbreaks Traced To Frozen Mice Sold As Food For Exotic Pets.
• Featured - Study finds diet and alcohol alter epigenetics of breast cancer
• Featured - New 'armor' developed to avoid infection from AIDS virus
• Featured - Reforestation projects capture more carbon than industrial plantations
• Featured - Decontaminating dangerous drywall
• Featured - Snake venom studies yield insights for development of therapies for heart disease and cancer
…full story

• FDA lifts hold on Geron study
• Orexigen weight-loss drug shows positive results in study
• Sanofi looks beyond blockbusters
• Molineaux turns her attention to start-up Calithera
• Charles River, WuXi call off $1.6B deal
• Anacor gets $15M from GSK
• Hospira plans big study for new Epogen biosimilar
• Athersys buoyed by upbeat PhI stem cell data
…full story

• CT Atlantic AG Announces Appointment of Michael Höcker to CEO
• Generex Provides Positive Update on Generex Oral-lyn Pivotal Phase III Trial
• Information on the risks and benefits of pesticides does not reach consumers
• One molecule, many more insulin-producing cells to treat diabetes, says Pitt team
• Aptuit and Siena Biotech Announce Strategic Relationship in Italy
• Bayer increases sales and earnings in the second quarter
• SynCo Bio Partners and Versartis Expand Collaboration as Lead Product Enters into Clinical Trials
• Plasma technology for solvent-free utility wood
…full story

• Biotage Launches New Isolera ELS Detector, Helps Isolate Virtually Any Compound
• CT Atlantic AG Announces Appointment of Michael Höcker to CEO
• Clontech Laboratories, Inc. & TET Systems Announce the Broadening of Their License ...
• AiCuris Presents Mechanism of Action Investigations of Its Novel Anti-HCMV Drug AIC246 at The ...
• Selvita Signs a Drug Discovery Services Contract With Rottapharm Madaus
• Bionas Adcon Reader for Impedance-based Cellular Analysis Launched
• Biotage Introduces Highly-Selective ExploraSep 96-Well Screening Plates based on Molecularly ...
• Encap Drug Delivery Receives Patent Approval for DuoCap Capsule System
…full story

• Curexo Technology Corp.: Series C $13.2M
• Ensysce Biosciences, Inc.: Series A $1.5M
• Green Biologics, Ltd.: Series B $6.1M
• Zymeworks, Inc.: Series B $3.2M
• Molecular Detection, Inc.: Series C $1.4M
• Zeltiq, Inc.: Series D $25M
• NanoPowers, SA: Series A $4.5M
• SynapDx Corp.: Series A $9M
…full story

• Science Daily Biotech: RNA Offers a Safer Way to Reprogram Cells For the first time, researchers have shown that they can deliver those same reprogramming genes using RNA, the genetic material that normally ferries instructions from DNA to the ... > full story …full story

• VCU's MDx Lab May Debut Next-Gen Sequencing in One Year
• Funds Hard To Come By On Proposed Tech Tax Break
• BIO Podcast with VaBIO Director Mark Herzog
• PA Borrows $30M for Vaccine Center
• Pfizer might get incentives to keep research center in Richmond
• Bode Technology Launches RFID System to Track DNA Evidence
• Biologists Tackle Cells' Identity Crisis
• RichTech Honors the Area’s Greatest Tech Firms and Folks
…full story

• CytRx's Tamibarotene Eradicates Former NBA Player's Aggressive, Advanced-Stage Leukemia
• Allos Therapeutics Announces Topline Results from Phase 2b Study of FOLOTYN in Patients with Advanced Non-Small Cell Lung Cancer
• Dynavax Promotes J. Tyler Martin, M.D. to President
• Advanced Life Sciences Applies for FDA Fast-Track Designation for Restanza in CABP
• Dynavax Completes Enrollment and First Immunizations in Universal Flu Vaccine Study …full story

• Tech Transfer for Business-Science Grads
• Thinking Beyond the Research Plan
• PSMJ Project Management Training
• Mining Industry goes to "Extremes"
• Gold Nanoparticles Control Oxidative Stress in Diabetic Mice
• Is Royalty Stacking Hindering Biotech Research?
• The Value of Biotechnology
• The Basics of Cancer-Causing Genes
…full story

• Did Mold Kill Brittany Murphy?
• Mycology Videos by David Fenster on Vimeo
• Five New Vids at Fungal Visions
• “Yeast Lords: The Bronco Years”
• Basil Fungus Making the Rounds
…full story

• This week: CBSA's popular BioBreakfast series features three CEO entrepreneurs
• July Issue: Focus Newsletter
• NATUREJobs.com -- Mile-high dreams
• CBSA Commends Boettcher Foundation on Historic Launch of Webb-Waring Biomedical Research Program & 1st Class of Boettcher Investigators
• DBJ Exclusive: "‘Fund of funds’ a top priority as Baumunk takes over CBSA"
• Colorado Industry Updates
• Video Recap: 2010 Boettcher Investigator Launch News Conference
• First Class of Boettcher Investigators Announced At Governor's Residence Ceremonies Today
…full story

• Consortia and commodities
• Pharma embraces open source models
• New eyes on old drugs
• Genetic testing clamp down
• New tech transfer models gain traction with deal flow
• French IPO spate
• Industrial biotech to boom?
• Sequencing firms vie for diagnostics market, tiptoe round patents …full story

• In this issue
• Biomarkers: the next generation
• Evolving R&D for emerging markets
• News in brief
• Deal watch: CureDM licenses regenerative diabetes therapy to Sanofi–Aventis
• Deal watch: The rise of option agreements
• Trial watch: Adaptive BATTLE trial uses biomarkers to guide lung cancer treatment …full story

• Allos Therapeutics: 08/10/09 Allos Therapeutics Announces FDA Advisory Committee to Review Pralatrexate for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma …full story

• Affygility: April 23, 2009
• Affygility Solutions releases Potent Compound Safety Self-Assessment Tool
• Affygility Solutions is pleased to announce the release of its Potent Compound Safety Self-Assessment Tool - PCSSAT™ to ensure safe potent compound handling.
• Based on industry expertise, PCSSAT™ allows life science companies the ability to self-evaluate their programs, procedures, and operational practices …full story